Phase 2 Study of the Safety, Tolerability and Pilot Efficacy of Oral Factor Xa Inhibitor Betrixaban Compared to Warfarin

NCT00742859 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

508

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: betrixaban
DRUG: Warfarin

Sponsor

Portola Pharmaceuticals